Trademarkia Logo

Canada

C$
QPARIKO
FORMALIZED

on 6 Feb 2025

Last Applicant/ Owned by

Incyte Holdings Corporation

1801 Augustine Cut-OffWilmington DE 19803

US

Serial Number

2378545 filed on 30th Dec 2024

QPARIKO

Trademark usage description

pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of myeloproliferativ Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of skeletal or chondrocyte disorders; pharmaceutical preparations for the treatment of myeloproliferative disorders; pharmaceutical preparations for the treatment of graft versus host disorder (GVHD); pharmaceutical preparations for the treatment of dermatological disorders; pharmaceutical preparations for the treatment of fibrotic disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of hematological disorders; pharmaceutical preparations for the treatment of immunological disorders; pharmaceutical preparations for the treatment of hypophosphatemia disorders.


Classification kind code

12

Class [016]
Printed brochures, newsletters, and pamphlets in the fields of medical issues, procedures, disease symptoms, patient support and community building.


Classification kind code

12

Class [044]
Providing medical information to healthcare providers and patients relating to viral, hematological, auto-immune, graft versus host, inflammatory, metabolic, fibrotic, skeletal, chondrocyte and dermatological disorders.


Classification kind code

12

Mark Details


Serial Number

2378545

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 257
on 6th Feb 2025
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 6th Feb 2025
Created
Submitted for opposition 31
on 6th Feb 2025
Formalized
Submitted for opposition 228
on 30th Dec 2024
International Registration
Submitted for opposition 30
on 30th Dec 2024
Filed